312 related articles for article (PubMed ID: 29957668)
1. Liquid Biopsies to Monitor Solid Organ Transplant Function: A Review of New Biomarkers.
Verhoeven JGHP; Boer K; Van Schaik RHN; Manintveld OC; Huibers MMH; Baan CC; Hesselink DA
Ther Drug Monit; 2018 Oct; 40(5):515-525. PubMed ID: 29957668
[TBL] [Abstract][Full Text] [Related]
2. New Markers for Transplant Rejection.
Argani H
Exp Clin Transplant; 2020 Jan; 18(Suppl 1):1-9. PubMed ID: 32008484
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction.
Quaglia M; Merlotti G; Guglielmetti G; Castellano G; Cantaluppi V
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751357
[TBL] [Abstract][Full Text] [Related]
4. Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study.
Jang MK; Tunc I; Berry GJ; Marboe C; Kong H; Keller MB; Shah PD; Timofte I; Brown AW; Ponor IL; Mutebi C; Philogene MC; Yu K; Iacono A; Orens JB; Nathan SD; Agbor-Enoh S
J Heart Lung Transplant; 2021 Aug; 40(8):822-830. PubMed ID: 34130911
[TBL] [Abstract][Full Text] [Related]
5. The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation.
Gielis EM; Ledeganck KJ; Dendooven A; Meysman P; Beirnaert C; Laukens K; De Schrijver J; Van Laecke S; Van Biesen W; Emonds MP; De Winter BY; Bosmans JL; Del Favero J; Abramowicz D
Nephrol Dial Transplant; 2020 Apr; 35(4):714-721. PubMed ID: 31106364
[TBL] [Abstract][Full Text] [Related]
6. The Monitoring of Donor-derived Cell-free DNA in Kidney Transplantation.
Filippone EJ; Farber JL
Transplantation; 2021 Mar; 105(3):509-516. PubMed ID: 32732615
[TBL] [Abstract][Full Text] [Related]
7. A Changing Paradigm in Heart Transplantation: An Integrative Approach for Invasive and Non-Invasive Allograft Rejection Monitoring.
Giarraputo A; Barison I; Fedrigo M; Burrello J; Castellani C; Tona F; Bottio T; Gerosa G; Barile L; Angelini A
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33535640
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles as potential diagnostic markers for kidney allograft rejection.
Thongwitokomarn H; Noppakun K; Chaiwarith R; Chattipakorn SC; Chattipakorn N
Clin Transplant; 2024 Apr; 38(4):e15314. PubMed ID: 38628057
[TBL] [Abstract][Full Text] [Related]
9. Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.
Agbor-Enoh S; Tunc I; De Vlaminck I; Fideli U; Davis A; Cuttin K; Bhatti K; Marishta A; Solomon MA; Jackson A; Graninger G; Harper B; Luikart H; Wylie J; Wang X; Berry G; Marboe C; Khush K; Zhu J; Valantine H
J Heart Lung Transplant; 2017 Sep; 36(9):1004-1012. PubMed ID: 28624139
[TBL] [Abstract][Full Text] [Related]
10. A Noninvasive and Donor-independent Method Simultaneously Monitors Rejection and Infection in Patients With Organ Transplant.
Zhou Y; Yang G; Liu H; Chen Y; Li X; Ge J; Wang X; Niu H; Dong W; Jiang T; Shi H; Peng L; Liu L
Transplant Proc; 2019; 51(6):1699-1705. PubMed ID: 31399160
[TBL] [Abstract][Full Text] [Related]
11. Donor-Derived Cell-Free DNA for the Detection of Heart Allograft Injury: The Impact of the Timing of the Liquid Biopsy.
Verhoeven JGHP; Hesselink DA; Peeters AMA; de Jonge E; von der Thüsen JH; van Schaik RHN; Matic M; Baan CC; Manintveld OC; Boer K
Transpl Int; 2022; 35():10122. PubMed ID: 35387397
[No Abstract] [Full Text] [Related]
12. Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
Hurkmans DP; Verhoeven JGHP; de Leur K; Boer K; Joosse A; Baan CC; von der Thüsen JH; van Schaik RHN; Mathijssen RHJ; van der Veldt AAM; Hesselink DA
J Immunother Cancer; 2019 Jul; 7(1):182. PubMed ID: 31300068
[TBL] [Abstract][Full Text] [Related]
13. Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions.
Kataria A; Kumar D; Gupta G
Transplantation; 2021 Jun; 105(6):1203-1211. PubMed ID: 33534526
[TBL] [Abstract][Full Text] [Related]
14. Using both the Fraction and Quantity of Donor-Derived Cell-Free DNA to Detect Kidney Allograft Rejection.
Bunnapradist S; Homkrailas P; Ahmed E; Fehringer G; Billings PR; Tabriziani H
J Am Soc Nephrol; 2021 Oct; 32(10):2439-2441. PubMed ID: 34162734
[No Abstract] [Full Text] [Related]
15. Next-generation sequencing methods to detect donor-derived cell-free DNA after transplantation.
Dengu F
Transplant Rev (Orlando); 2020 Jul; 34(3):100542. PubMed ID: 32265093
[TBL] [Abstract][Full Text] [Related]
16. Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study.
Verhoeven JGHP; Baan CC; Peeters AMA; Clahsen-van Groningen MC; Nieboer D; Herzog M; Eccleston M; Hesselink DA; Boer K
Clin Epigenetics; 2021 Feb; 13(1):32. PubMed ID: 33573704
[TBL] [Abstract][Full Text] [Related]
17. Cell-free DNA diagnostics in transplantation utilizing next generation sequencing.
Jackson AM; Amato-Menker C; Bettinotti M
Hum Immunol; 2021 Nov; 82(11):850-858. PubMed ID: 34600770
[TBL] [Abstract][Full Text] [Related]
18. Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches.
Edwards RL; Menteer J; Lestz RM; Baxter-Lowe LA
Biomark Med; 2022 Apr; 16(5):401-415. PubMed ID: 35195028
[TBL] [Abstract][Full Text] [Related]
19. Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value Proposition.
Oellerich M; Christenson RH; Beck J; Schütz E; Sherwood K; Price CP; Keown PA; Walson PD
J Appl Lab Med; 2020 Sep; 5(5):993-1004. PubMed ID: 32447378
[TBL] [Abstract][Full Text] [Related]
20. Circulating extracellular vesicles as non-invasive biomarker of rejection in heart transplant.
Castellani C; Burrello J; Fedrigo M; Burrello A; Bolis S; Di Silvestre D; Tona F; Bottio T; Biemmi V; Toscano G; Gerosa G; Thiene G; Basso C; Longnus SL; Vassalli G; Angelini A; Barile L
J Heart Lung Transplant; 2020 Oct; 39(10):1136-1148. PubMed ID: 32665078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
